Trauth, JaninaJaninaTrauthSchuler, RahelRahelSchulerWaitz, MarkusMarkusWaitzEhrhardt, HaraldHaraldEhrhardtFritzenwanker, MoritzMoritzFritzenwankerHerold, SusanneSusanneHerold2025-03-192025-03-192024https://jlupub.ub.uni-giessen.de/handle/jlupub/20340https://doi.org/10.22029/jlupub-19691Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.enNamensnennung 4.0 Internationalddc:610Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol